{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Wilmington",
      "address_1": "1800 Concord Pike",
      "reason_for_recall": "Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿  XR tablets.",
      "address_2": "",
      "product_quantity": "34,524 bottles",
      "code_info": "Lot # FC0064; Exp. 05/17",
      "center_classification_date": "20150618",
      "distribution_pattern": "Nationwide to wholesalers for further distribution at the retail level.",
      "state": "DE",
      "product_description": "NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.",
      "report_date": "20150624",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "AstraZeneca Pharmaceuticals LP",
      "recall_number": "D-1141-2015",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "71483",
      "termination_date": "20160927",
      "more_code_info": "",
      "recall_initiation_date": "20150610",
      "postal_code": "19850",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}